Deep Track Capital’s AnaptysBio ANAB Stock Holding History

Deep Track Capital’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-529,452	Closed	-$11.9M	–	69
2024 Q1	$11.9M	Sell	529,452 -1,507,538	-74%	-$35.7M	0.34%	52
2023 Q4	$43.6M	Buy	2,036,990 +691,177	+51%	+$11.9M	1.46%	29
2023 Q3	$24.2M	Buy	+1,345,813	New	+$25.7M	0.93%	32
2022 Q4	–	Sell	-360,000	Closed	-$9.18M	–	63
2022 Q3	$9.18M	Sell	360,000 -312,569	-46%	-$7.33M	0.42%	52
2022 Q2	$13.7M	Buy	672,569 +113,787	+20%	+$2.52M	0.9%	33
2022 Q1	$13.8M	Buy	+558,782	New	+$16.9M	0.89%	33

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Deep Track Capital's ANAB Position: Q2 2024 in Review

Deep Track Capital sold out of AnaptysBio (ANAB) in Q2 2024, closing a stake of 529,452 shares — an estimated $11.9M sold.

Deep Track Capital first reported a position in ANAB in Q1 2022 and held it in 6 quarters. The position peaked at $43.6M in Q4 2023. 135 funds tracked by Wall St. Rank hold ANAB as of Q2 2024.

Deep Track Capital reported no remaining AnaptysBio position as of Q2 2024 after selling out during the quarter.
Deep Track Capital sold 529,452 AnaptysBio shares in Q2 2024, an estimated $11.9M.
Deep Track Capital first reported a position in AnaptysBio in Q1 2022 and held it in 6 quarters.
Deep Track Capital's AnaptysBio position peaked at $43.6M in Q4 2023.
135 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2024.

Based on Deep Track Capital's 13F filing for Q2 2024, filed 14 Aug 2024.